KV2.2 Antibodies

Santa Cruz Biotechnology delivers a wide array of KV2.2 monoclonal antibodies for research focused on understanding KV2.2 protein's role in various cellular processes. The monoclonal antibodies are validated for multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KV2.2, also known as KCNB2, is a voltage-gated potassium channel that plays a critical role in regulating neuronal excitability and action potential firing. The proper function of KV2.2 is essential for maintaining the electrical balance in cells, influencing processes such as neurotransmitter release and muscle contraction. Dysregulation of KV2.2 has been implicated in various neurological disorders, making it a significant target for research in neurobiology and pharmacology. Research involving KV2.2 has revealed its importance in maintaining proper neural function and cellular homeostasis. Understanding KV2.2 function can provide valuable insights into potential therapeutic approaches for neurological conditions. Investigating KV2.2 expression patterns helps researchers better understand its distribution across different tissue types and cellular compartments. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of KV2.2's role in neurological health and disease.